VCEL: Vericel Corporation
Performance
VCEL +49.95%
Watchlist
Select an item
Summary
VCEL at a glance
VCEL returned +49.95% over the past year and +4.85% a year over five years. Its worst drop in that year was -31.03%, smaller than 55% of stocks on Redstone, and its Sharpe ratio of 1.04 beats 77% of stocks on Redstone. It pays no dividends.
Current Drawdown
0.00%
Rolling Volatility
72.05%
Actions
Metrics
Risk Indicators
Alpha41.99%
Beta0.51x
Sharpe1.04
Sortino1.69
Omega1.19
Calmar1.61
Martin3.17
Profile
About VCEL
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $3.0B
- Listed
- Feb 1997
- Employees
- 398
- Headquarters
- Burlington, MA
- Website
- vcel.com
Comparisons